Mycophenolate mofetil and Nadolol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Nadolol (nadolol). Common drug interactions include productive cough among females and chronic lymphocytic leukaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Nadolol. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Nadolol?

Nadolol has active ingredients of nadolol. It is often used in high blood pressure. eHealthMe is studying from 4,476 Nadolol users. Check the latest studies of Nadolol.

On Jul, 06, 2026

34 people who take Mycophenolate mofetil and Nadolol together, and have interactions are studied.

Mycophenolate mofetil and Nadolol drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Nadolol, by gender? *:

female:

Productive cough
Pulmonary hypertension (increase in blood pressure in the lung artery)
Respiratory disorder (respiratory disease)
Sinus congestion (blockage of sinus)
Skin injury
Somnolence (a state of near-sleep, a strong desire for sleep)
Ventricular dysfunction (heart dysfunction)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Weight decreased
Bilirubin conjugated increased

male:

Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Infusion site haemorrhage (bleeding from infusion site)
Seborrhoeic keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest)
Skin cancer
Tachyphylaxis (a medical term describing an acute (sudden) decrease in the response to a drug after its administration)
Thrombocytopenia (decrease of platelets in blood)
Abdominal abscess (collection of pus in abdomen)
Abdominal distension
Abdominal pain
Arthralgia (joint pain)

What are the common drug interactions of Mycophenolate Mofetil and Nadolol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Aspartate aminotransferase increased
Cardiac failure congestive
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Lipids increased (excess lipid in body)
Ventricular dysfunction (heart dysfunction)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Bilirubin conjugated increased
Blood albumin decreased
Blood albumin increased
Dilatation ventricular

10-19:

Anaphylactic reaction (serious allergic reaction)
Blood creatinine increased
Diarrhoea
Drug level increased
Feeling cold
Feeling hot
Glossodynia (a burning or painful sensation in the tongue)
Headache (pain in head)
Lip pain
Nausea (feeling of having an urge to vomit)

20-29:

Death
Optic ischaemic neuropathy (optic nerve damage due to lack of blood supply)

30-39:

n/a

40-49:

Diarrhoea
Immunosuppressant drug level increased
Psoriasis (immune-mediated disease that affects the skin)
Liver disorder (liver diseases)
Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)

50-59:

Back pain
Chills (felling of cold)
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Pyrexia (fever)
Anxiety
Asthenia (weakness)
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Bone pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Infusion site haemorrhage (bleeding from infusion site)
Fatigue (feeling of tiredness)
Headache (pain in head)
Infusion site discomfort
Injection site extravasation (flow of (blood or lymph) from injection site)
Muscle tightness
Osteitis (a general term for inflammation of bone)
Salivary gland pain
Platelet count decreased

What are the existing conditions these people have? *

Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 9 people, 26.47%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 23.53%
Epstein-Barr Virus Associated Lymphoma (epstein-barr virus associated tumour): 8 people, 23.53%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 6 people, 17.65%
Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 17.65%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 14.71%
Acute Kidney Failure: 5 people, 14.71%
Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 3 people, 8.82%
Sleep Apnea Syndrome: 3 people, 8.82%
Pvt: 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Nadolol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously